MEOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Methanex Corp (MEOH) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the stock has some positive catalysts such as bullish moving averages and favorable geopolitical developments, the lack of strong proprietary trading signals, declining financial performance, and neutral trading sentiment make it prudent to hold off on investing immediately. The investor may consider monitoring the stock for better entry points or improved financial performance.
The stock's technical indicators show mixed signals. The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 46.864, suggesting no clear signal. However, the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near a key support level (S1: 47.238).
Bullish moving averages indicate potential upward momentum.
Geopolitical events may support Methanex's operations and lead to tighter methanol market balances, potentially driving higher prices and margins.
Analyst price targets have been revised upward, with RBC Capital forecasting an upward price trend through 2028.
Financial performance in Q3 2025 showed significant declines in revenue (-0.79% YoY), net income (-122.76% YoY), and EPS (-125.71% YoY).
MACD and RSI do not provide strong buy signals.
No recent congress trading data or significant insider/hedge fund activity to support a strong buy case.
Methanex's Q3 2025 financials showed a decline in revenue to $927.4M (-0.79% YoY), net income dropped to -$7.07M (-122.76% YoY), and EPS fell to -$0.09 (-125.71% YoY). However, gross margin improved to 7.38 (+67.35% YoY), indicating some operational efficiency gains.
Analyst sentiment is mixed. CIBC downgraded the stock to Neutral with a price target of $52, while RBC Capital raised its price target to $55 and maintained an Outperform rating. Scotiabank sees geopolitical events as a positive driver for Methanex's operations and maintains an Outperform rating with a $48 price target.
